Share on StockTwits
 

Elizabeth Arden (NASDAQ:RDEN) was downgraded by Zacks from a “neutral” rating to an “underperform” rating in a research report issued on Tuesday, American Banking & Market News reports. They currently have a $26.60 price target on the stock. Zacks‘ price objective suggests a potential downside of 4.86% from the stock’s previous close.

Elizabeth Arden (NASDAQ:RDEN) traded up 1.93% during mid-day trading on Tuesday, hitting $28.50. 413,521 shares of the company’s stock traded hands. Elizabeth Arden has a 52-week low of $27.70 and a 52-week high of $49.47. The stock’s 50-day moving average is $35.51 and its 200-day moving average is $37.79. The company has a market cap of $845.9 million and a price-to-earnings ratio of 21.17.

Elizabeth Arden (NASDAQ:RDEN) last released its earnings data on Wednesday, October 30th. The company reported $0.22 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.15 by $0.07. The company had revenue of $343.60 million for the quarter, compared to the consensus estimate of $342.13 million. During the same quarter in the prior year, the company posted $0.44 earnings per share. The company’s quarterly revenue was down .3% on a year-over-year basis. Analysts expect that Elizabeth Arden will post $2.07 EPS for the current fiscal year.

A number of other analysts have also recently weighed in on RDEN. Analysts at B. Riley cut their price target on shares of Elizabeth Arden from $42.00 to $30.00 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock. Separately, analysts at Telsey Advisory Group cut their price target on shares of Elizabeth Arden from $35.00 to $30.00 in a research note to investors on Friday. They now have a “not rated” rating on the stock. Finally, analysts at CJS Securities downgraded shares of Elizabeth Arden from an “outperform” rating to a “market perform” rating in a research note to investors on Friday. They now have a $30.00 price target on the stock, down previously from $40.00. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. Elizabeth Arden has a consensus rating of “Hold” and an average target price of $35.70.

Elizabeth Arden, Inc is a beauty products company with a range of portfolio of fragrance, skin care and cosmetics brands.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.